Federal contractor profile
VENATORX PHARMACEUTICALS INC
UEI MBBKNBU5DCC6CAGE 61SY9
Active
Small Business
Overview
- Legal name
- VENATORX PHARMACEUTICALS INC
- Registered location
- CHADDS FORD, PA, USA
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Latest award activity
- Jul 31, 2026
Read company summary
VENATORX PHARMACEUTICALS INC is associated with UEI MBBKNBU5DCC6 and CAGE 61SY9 in public federal records. AcornBids currently links 4 prime awards totaling $241.5M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists CHADDS FORD, PA, USA.
At a glance
Lifetime prime obligations$241.5M
Prime awards4
Awards with future end dates1
Top-agency concentration94.1%
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- VENATORX PHARMACEUTICALS INC
- UEI
- MBBKNBU5DCC6
- CAGE
- 61SY9
- Registered address
- 110 COMMONS CT, CHADDS FORD, PA, 19317, USA
- Registration status
- Active
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- SAM activation
- Dec 10, 2025
- Initial registration
- Jun 26, 2010
- Entity start
- Jun 4, 2010
- SAM updated
- Dec 10, 2025
- Registration expires
- Dec 8, 2026
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| HHSN272201600029CIGF::OT::IGF - ORALLY BIOAVAILABLEβ-LACTAM/β-LACTAMASE INHIBITOR COMBINATION FOR BIODEFENSE AND PUBLIC HEALTH. | Department of Health and Human Services | $48.5M | Sep 19, 2016 | Mar 31, 2026 |
| 75A50119C00007VENATORX PHARMACEUTICALS, INC. | Department of Health and Human Services | $131.8M | Jul 17, 2019 | Sep 30, 2025 |
| 75A50122C00080VENATORX PHARMACEUTICALS: ANTIBIOTIC FOR AMR AND BIOTHREAT PATHOGENS | Department of Health and Human Services | $72.1M | Sep 27, 2022 | Sep 22, 2032 |
| HDTRA117C0070PENICILLIN BINDING PROTEINS IGF::OT::IGF | Department of Defense | $14.7M | Aug 28, 2017 | Oct 27, 2023 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Dec 10, 2025 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Jun 26, 2010 |
| Entity start | Jun 4, 2010 |
Registration classifications: Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| YI SHI | Government business | Contact method not published | SAM registration | Not available |
| YI SHI | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Registered products and services
- 6509 — Drugs and Biologicals, Veterinary Use.
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
49 awards
26 awards
25 awards
20 awards
18 awards
16 awards
15 awards
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit